Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05WSU
|
|||
| Former ID |
DNC002797
|
|||
| Drug Name |
Beta-D-Glucopyranose Spirohydantoin
|
|||
| Synonyms |
BETA-D-GLUCOPYRANOSE SPIROHYDANTOIN; CHEMBL510975; GLS; (5S,7R,8S,9S,10R)-8,9,10-trihydroxy-7-(hydroxymethyl)-6-oxa-1,3-diazaspiro[4.5]decane-2,4-dione; 1a8i; AC1L9FVJ; BDBM50263768; 1beta,1-(Iminocarbonyliminocarbonyl)-1-deoxy-D-glucopyranose; (5S,7R,8S,9S,10R)-8,9,10-Trihydroxy-7-hydroxymethyl-6-oxa-1,3-diaza-spiro[4.5]decane-2,4-dione
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C8H12N2O7
|
|||
| Canonical SMILES |
C(C1C(C(C(C2(O1)C(=O)NC(=O)N2)O)O)O)O
|
|||
| InChI |
1S/C8H12N2O7/c11-1-2-3(12)4(13)5(14)8(17-2)6(15)9-7(16)10-8/h2-5,11-14H,1H2,(H2,9,10,15,16)/t2-,3-,4+,5-,8+/m1/s1
|
|||
| InChIKey |
QRXBDPYWCAAAAI-WWHASAIZSA-N
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Glycogen phosphorylase muscle form (GP) | Target Info | Inhibitor | [1] |
| BioCyc | Glycogenolysis | |||
| KEGG Pathway | Starch and sucrose metabolism | |||
| Metabolic pathways | ||||
| Insulin signaling pathway | ||||
| Glucagon signaling pathway | ||||
| Panther Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||
| WikiPathways | Glycogen Metabolism | |||
| Metabolism of carbohydrates | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.